ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #6,325Hybrid

Familial Cancer

Acronym:fame
•
Abbreviation (ISO):FAM CANCER
•
Identifier (ISSN):1389-9600(Print)/1573-7292(Online)
•
Publisher:Springer Netherlands
Clarivate IF (2026)
2.1↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Familial Cancer

WoS Q3
12341.9420182.2120192.3820212.4520222.220231.82024220252.12026
Annual Impact Factor Metric
Current (2026):2.1
Scopus SJR & RankScopus Q2
0.849
#6,325

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
72

72 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate5.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
54articles/year
47.65% Gold OA•82.05% Original Research

Aims & Scope

In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers. Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician. The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.

Topics Covered (Recognized by AI)
Medicine99%Biology96.6%Genetics95.5%Internal medicine92.2%Cancer77.6%Chemistry77%Biochemistry76.7%Gene74%Pathology56.6%Mutation45.6%Colorectal cancer39.4%Oncology35.9%Germline mutation35.7%Surgery32.9%DNA29.9%DNA repair27%Radiology26.9%Breast cancer26.5%DNA mismatch repair24.6%Lynch syndrome22%Sociology20.9%Epidemiology20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

GENETICS & HEREDITY

Q3
Rank125/192
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q3
Rank236/333
IndexSCIE
JCISCIE2026

GENETICS & HEREDITY

Q3
Rank143/192
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank242/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.1
Articles / Year75
Total Citations13
2025
IF2
Articles / Year84
Total Citations155
2024
IF1.8
Articles / Year83
Total Citations417
2023
IF2.2
Articles / Year27
Total Citations159
2022
IF2.446
Articles / Year40
Total Citations315

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,325Scopus Q2SCImago Profile
Scopus Coverage:2001, 2003-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.849

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.19

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,276 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations391
3-Year Documents171
Citable Documents164

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate60.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GeneticsQ2
Genetics (clinical)Q2
OncologyQ2
Cancer ResearchQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Familial Cancer (acronym: fame, abbr: FAM CANCER, ISSN: 1389-9600) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Netherlands in Netherlands since 2001. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.849 (Q2), an H-index of 72.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 54 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,276 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Netherlands
Publication Language
English
Frequency
Quarterly
Founding Year
2001
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 9539a14e-870d-4d12-a6dc-fbeea1d0589c
Database Updated: 2026-10-01